サマリー

心血管治療薬の世界市場 2023-2027
Technavioは、心血管治療薬市場をモニターしており、2022年から2027年の間に377億7000万ドル、予測期間中のCAGRは7.32%で加速して成長すると予測しています。当レポートでは、心血管治療薬市場について、全体的な分析、市場規模と予測、トレンド、成長ドライバー、課題、さらに約25のベンダーをカバーするベンダー分析などを掲載しています。
現在の市場シナリオ、最新のトレンドとドライバー、市場全体の環境に関する最新の分析を提供しています。市場は、心血管疾患のリスク要因の増加、高度な診断方法の利用可能性、高コレステロール血症の有病率の上昇によって牽引されています。
Technavioの心血管治療薬市場は以下のようにセグメント化されています：
タイプ別
- 抗血栓薬
- 高脂血症治療薬
- その他
流通チャネル別
- 病院薬局
- リテールファーマシー
- オンラインファーマシー
地理的景観別
- 亜細亜
- 北アメリカ
- ヨーロッパ
- レスト・オブ・ワールド（ROW）
本調査では、新規経口抗凝固薬（NOAC）の登場が、今後数年間の心血管治療薬市場の成長を促進する主要な理由の1つであると特定しています。また、新たな病原性標的の特定と冠動脈性心疾患（CHD）の旺盛な発生が、市場の大きな需要につながるとしています。
Technavioは、主要パラメータの分析によって、複数のソースからのデータを調査、合成、要約する方法で、市場の詳細な画像を提示します。当レポートでは、心血管治療薬市場について、以下の分野を取り上げています：
- 心血管治療薬市場のサイジング
- 心血管治療薬市場予測
- 心血管治療薬市場の業界分析
Technavioの強固なベンダー分析は、お客様が市場での地位を向上できるように設計されており、これに沿って、本レポートでは、Abbott Laboratories、Acutus Medical Inc、Amgen Inc、Astellas Pharma Inc、AstraZeneca Plc、Aurobindo Pharma Ltd、Bayer AG、Boehringer Ingelheim International GmbH、Bristol Myers Squibb Co、Dichi Sankyo Co.など複数の主要循環器治療薬の市場ベンダーに関する詳細分析を提供します。Ltd.、Dr. Reddys Laboratories Ltd.、Eli Lilly and Co.、F. Hoffmann La Roche Ltd.、GlaxoSmithKline Plc、Johnson and Johnson Services Inc.、Merck and Co.Inc.、Novartis AG、Pfizer Inc.、Sun Pharmaceutical Industries Ltd.、Viatris Inc.などです。また、心血管治療薬市場の分析レポートには、今後の動向と市場成長に影響を与える課題に関する情報も含まれています。これは、企業が戦略を立て、今後訪れるすべての成長機会を活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む一次情報と二次情報を客観的に組み合わせて実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/cardiovascular-therapeutics-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析によって、複数のソースからのデータを調査、合成、要約する方法で、市場の詳細な画像を提示します。また、業界の主要なインフルエンサーを特定することで、様々な市場の様相を提示しています。提示されるデータは、包括的で信頼性が高く、一次および二次にわたる広範な調査の結果である。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた詳細なベンダー選択方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global cardiovascular therapeutics market 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on Global cardiovascular therapeutics market 2017 - 2021 ($ billion)
o 4.2 Type Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - Type Segment 2017 - 2021 ($ billion)
o 4.3 Distribution channel Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - Distribution channel Segment 2017 - 2021 ($ billion)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by Type
o 6.1 Market segments
o Exhibit 30: Chart on Type - Market share 2022-2027 (%)
o Exhibit 31: Data Table on Type - Market share 2022-2027 (%)
o 6.2 Comparison by Type
o Exhibit 32: Chart on Comparison by Type
o Exhibit 33: Data Table on Comparison by Type
o 6.3 Antithrombotic drugs - Market size and forecast 2022-2027
o Exhibit 34: Chart on Antithrombotic drugs - Market size and forecast 2022-2027 ($ billion)
o Exhibit 35: Data Table on Antithrombotic drugs - Market size and forecast 2022-2027 ($ billion)
o Exhibit 36: Chart on Antithrombotic drugs - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Antithrombotic drugs - Year-over-year growth 2022-2027 (%)
o 6.4 Hypolipidemic drugs - Market size and forecast 2022-2027
o Exhibit 38: Chart on Hypolipidemic drugs - Market size and forecast 2022-2027 ($ billion)
o Exhibit 39: Data Table on Hypolipidemic drugs - Market size and forecast 2022-2027 ($ billion)
o Exhibit 40: Chart on Hypolipidemic drugs - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Hypolipidemic drugs - Year-over-year growth 2022-2027 (%)
o 6.5 Others - Market size and forecast 2022-2027
o Exhibit 42: Chart on Others - Market size and forecast 2022-2027 ($ billion)
o Exhibit 43: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
o Exhibit 44: Chart on Others - Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Others - Year-over-year growth 2022-2027 (%)
o 6.6 Market opportunity by Type
o Exhibit 46: Market opportunity by Type ($ billion)
o Exhibit 47: Data Table on Market opportunity by Type ($ billion)
• 7 Market Segmentation by Distribution Channel
o 7.1 Market segments
o Exhibit 48: Chart on Distribution Channel - Market share 2022-2027 (%)
o Exhibit 49: Data Table on Distribution Channel - Market share 2022-2027 (%)
o 7.2 Comparison by Distribution Channel
o Exhibit 50: Chart on Comparison by Distribution Channel
o Exhibit 51: Data Table on Comparison by Distribution Channel
o 7.3 Hospital pharmacy - Market size and forecast 2022-2027
o Exhibit 52: Chart on Hospital pharmacy - Market size and forecast 2022-2027 ($ billion)
o Exhibit 53: Data Table on Hospital pharmacy - Market size and forecast 2022-2027 ($ billion)
o Exhibit 54: Chart on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
o Exhibit 55: Data Table on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
o 7.4 Retail pharmacy - Market size and forecast 2022-2027
o Exhibit 56: Chart on Retail pharmacy - Market size and forecast 2022-2027 ($ billion)
o Exhibit 57: Data Table on Retail pharmacy - Market size and forecast 2022-2027 ($ billion)
o Exhibit 58: Chart on Retail pharmacy - Year-over-year growth 2022-2027 (%)
o Exhibit 59: Data Table on Retail pharmacy - Year-over-year growth 2022-2027 (%)
o 7.5 Online pharmacy - Market size and forecast 2022-2027
o Exhibit 60: Chart on Online pharmacy - Market size and forecast 2022-2027 ($ billion)
o Exhibit 61: Data Table on Online pharmacy - Market size and forecast 2022-2027 ($ billion)
o Exhibit 62: Chart on Online pharmacy - Year-over-year growth 2022-2027 (%)
o Exhibit 63: Data Table on Online pharmacy - Year-over-year growth 2022-2027 (%)
o 7.6 Market opportunity by Distribution Channel
o Exhibit 64: Market opportunity by Distribution Channel ($ billion)
o Exhibit 65: Data Table on Market opportunity by Distribution Channel ($ billion)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 67: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 69: Chart on Geographic comparison
o Exhibit 70: Data Table on Geographic comparison
o 9.3 Asia - Market size and forecast 2022-2027
o Exhibit 71: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
o Exhibit 72: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
o Exhibit 73: Chart on Asia - Year-over-year growth 2022-2027 (%)
o Exhibit 74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
o 9.4 North America - Market size and forecast 2022-2027
o Exhibit 75: Chart on North America - Market size and forecast 2022-2027 ($ billion)
o Exhibit 76: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
o Exhibit 77: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.5 Europe - Market size and forecast 2022-2027
o Exhibit 79: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
o Exhibit 80: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
o Exhibit 81: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
o Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
o Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
o Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o 9.7 US - Market size and forecast 2022-2027
o Exhibit 87: Chart on US - Market size and forecast 2022-2027 ($ billion)
o Exhibit 88: Data Table on US - Market size and forecast 2022-2027 ($ billion)
o Exhibit 89: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.8 China - Market size and forecast 2022-2027
o Exhibit 91: Chart on China - Market size and forecast 2022-2027 ($ billion)
o Exhibit 92: Data Table on China - Market size and forecast 2022-2027 ($ billion)
o Exhibit 93: Chart on China - Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on China - Year-over-year growth 2022-2027 (%)
o 9.9 India - Market size and forecast 2022-2027
o Exhibit 95: Chart on India - Market size and forecast 2022-2027 ($ billion)
o Exhibit 96: Data Table on India - Market size and forecast 2022-2027 ($ billion)
o Exhibit 97: Chart on India - Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on India - Year-over-year growth 2022-2027 (%)
o 9.10 Russia - Market size and forecast 2022-2027
o Exhibit 99: Chart on Russia - Market size and forecast 2022-2027 ($ billion)
o Exhibit 100: Data Table on Russia - Market size and forecast 2022-2027 ($ billion)
o Exhibit 101: Chart on Russia - Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on Russia - Year-over-year growth 2022-2027 (%)
o 9.11 Mexico - Market size and forecast 2022-2027
o Exhibit 103: Chart on Mexico - Market size and forecast 2022-2027 ($ billion)
o Exhibit 104: Data Table on Mexico - Market size and forecast 2022-2027 ($ billion)
o Exhibit 105: Chart on Mexico - Year-over-year growth 2022-2027 (%)
o Exhibit 106: Data Table on Mexico - Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 107: Market opportunity By Geographical Landscape ($ billion)
o Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ billion)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 109: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 111: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 112: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 113: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 114: Matrix on vendor position and classification
o 12.3 Abbott Laboratories
o Exhibit 115: Abbott Laboratories - Overview
o Exhibit 116: Abbott Laboratories - Business segments
o Exhibit 117: Abbott Laboratories - Key offerings
o Exhibit 118: Abbott Laboratories - Segment focus
o 12.4 Astellas Pharma Inc.
o Exhibit 119: Astellas Pharma Inc. - Overview
o Exhibit 120: Astellas Pharma Inc. - Product / Service
o Exhibit 121: Astellas Pharma Inc. - Key news
o Exhibit 122: Astellas Pharma Inc. - Key offerings
o 12.5 AstraZeneca Plc
o Exhibit 123: AstraZeneca Plc - Overview
o Exhibit 124: AstraZeneca Plc - Product / Service
o Exhibit 125: AstraZeneca Plc - Key news
o Exhibit 126: AstraZeneca Plc - Key offerings
o 12.6 Aurobindo Pharma Ltd.
o Exhibit 127: Aurobindo Pharma Ltd. - Overview
o Exhibit 128: Aurobindo Pharma Ltd. - Product / Service
o Exhibit 129: Aurobindo Pharma Ltd. - Key offerings
o 12.7 Bayer AG
o Exhibit 130: Bayer AG - Overview
o Exhibit 131: Bayer AG - Business segments
o Exhibit 132: Bayer AG - Key news
o Exhibit 133: Bayer AG - Key offerings
o Exhibit 134: Bayer AG - Segment focus
o 12.8 Boehringer Ingelheim International GmbH
o Exhibit 135: Boehringer Ingelheim International GmbH - Overview
o Exhibit 136: Boehringer Ingelheim International GmbH - Business segments
o Exhibit 137: Boehringer Ingelheim International GmbH - Key news
o Exhibit 138: Boehringer Ingelheim International GmbH - Key offerings
o Exhibit 139: Boehringer Ingelheim International GmbH - Segment focus
o 12.9 Bristol Myers Squibb Co.
o Exhibit 140: Bristol Myers Squibb Co. - Overview
o Exhibit 141: Bristol Myers Squibb Co. - Product / Service
o Exhibit 142: Bristol Myers Squibb Co. - Key news
o Exhibit 143: Bristol Myers Squibb Co. - Key offerings
o 12.10 Daiichi Sankyo Co. Ltd.
o Exhibit 144: Daiichi Sankyo Co. Ltd. - Overview
o Exhibit 145: Daiichi Sankyo Co. Ltd. - Business segments
o Exhibit 146: Daiichi Sankyo Co. Ltd. - Key news
o Exhibit 147: Daiichi Sankyo Co. Ltd. - Key offerings
o Exhibit 148: Daiichi Sankyo Co. Ltd. - Segment focus
o 12.11 Dr Reddys Laboratories Ltd.
o Exhibit 149: Dr Reddys Laboratories Ltd. - Overview
o Exhibit 150: Dr Reddys Laboratories Ltd. - Business segments
o Exhibit 151: Dr Reddys Laboratories Ltd. - Key offerings
o Exhibit 152: Dr Reddys Laboratories Ltd. - Segment focus
o 12.12 Eli Lilly and Co.
o Exhibit 153: Eli Lilly and Co. - Overview
o Exhibit 154: Eli Lilly and Co. - Product / Service
o Exhibit 155: Eli Lilly and Co. - Key offerings
o 12.13 GlaxoSmithKline Plc
o Exhibit 156: GlaxoSmithKline Plc - Overview
o Exhibit 157: GlaxoSmithKline Plc - Business segments
o Exhibit 158: GlaxoSmithKline Plc - Key news
o Exhibit 159: GlaxoSmithKline Plc - Key offerings
o Exhibit 160: GlaxoSmithKline Plc - Segment focus
o 12.14 Johnson and Johnson Services Inc.
o Exhibit 161: Johnson and Johnson Services Inc. - Overview
o Exhibit 162: Johnson and Johnson Services Inc. - Business segments
o Exhibit 163: Johnson and Johnson Services Inc. - Key news
o Exhibit 164: Johnson and Johnson Services Inc. - Key offerings
o Exhibit 165: Johnson and Johnson Services Inc. - Segment focus
o 12.15 Merck and Co. Inc.
o Exhibit 166: Merck and Co. Inc. - Overview
o Exhibit 167: Merck and Co. Inc. - Business segments
o Exhibit 168: Merck and Co. Inc. - Key news
o Exhibit 169: Merck and Co. Inc. - Key offerings
o Exhibit 170: Merck and Co. Inc. - Segment focus
o 12.16 Pfizer Inc.
o Exhibit 171: Pfizer Inc. - Overview
o Exhibit 172: Pfizer Inc. - Product / Service
o Exhibit 173: Pfizer Inc. - Key news
o Exhibit 174: Pfizer Inc. - Key offerings
o 12.17 Viatris Inc.
o Exhibit 175: Viatris Inc. - Overview
o Exhibit 176: Viatris Inc. - Business segments
o Exhibit 177: Viatris Inc. - Key offerings
o Exhibit 178: Viatris Inc. - Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 179: Inclusions checklist
o Exhibit 180: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 181: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 182: Research methodology
o Exhibit 183: Validation techniques employed for market sizing
o Exhibit 184: Information sources
o 13.5 List of abbreviations
o Exhibit 185: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on Global cardiovascular therapeutics market 2017 - 2021 ($ billion)
Exhibits19: Historic Market Size - Type Segment 2017 - 2021 ($ billion)
Exhibits20: Historic Market Size - Distribution channel Segment 2017 - 2021 ($ billion)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Type - Market share 2022-2027 (%)
Exhibits31: Data Table on Type - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Type
Exhibits33: Data Table on Comparison by Type
Exhibits34: Chart on Antithrombotic drugs - Market size and forecast 2022-2027 ($ billion)
Exhibits35: Data Table on Antithrombotic drugs - Market size and forecast 2022-2027 ($ billion)
Exhibits36: Chart on Antithrombotic drugs - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Antithrombotic drugs - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Hypolipidemic drugs - Market size and forecast 2022-2027 ($ billion)
Exhibits39: Data Table on Hypolipidemic drugs - Market size and forecast 2022-2027 ($ billion)
Exhibits40: Chart on Hypolipidemic drugs - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Hypolipidemic drugs - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Others - Market size and forecast 2022-2027 ($ billion)
Exhibits43: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
Exhibits44: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits46: Market opportunity by Type ($ billion)
Exhibits47: Data Table on Market opportunity by Type ($ billion)
Exhibits48: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibits49: Data Table on Distribution Channel - Market share 2022-2027 (%)
Exhibits50: Chart on Comparison by Distribution Channel
Exhibits51: Data Table on Comparison by Distribution Channel
Exhibits52: Chart on Hospital pharmacy - Market size and forecast 2022-2027 ($ billion)
Exhibits53: Data Table on Hospital pharmacy - Market size and forecast 2022-2027 ($ billion)
Exhibits54: Chart on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits56: Chart on Retail pharmacy - Market size and forecast 2022-2027 ($ billion)
Exhibits57: Data Table on Retail pharmacy - Market size and forecast 2022-2027 ($ billion)
Exhibits58: Chart on Retail pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Retail pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits60: Chart on Online pharmacy - Market size and forecast 2022-2027 ($ billion)
Exhibits61: Data Table on Online pharmacy - Market size and forecast 2022-2027 ($ billion)
Exhibits62: Chart on Online pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits63: Data Table on Online pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits64: Market opportunity by Distribution Channel ($ billion)
Exhibits65: Data Table on Market opportunity by Distribution Channel ($ billion)
Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits67: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits69: Chart on Geographic comparison
Exhibits70: Data Table on Geographic comparison
Exhibits71: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibits72: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibits73: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on North America - Market size and forecast 2022-2027 ($ billion)
Exhibits76: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
Exhibits77: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibits80: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibits81: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibits84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibits85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on US - Market size and forecast 2022-2027 ($ billion)
Exhibits88: Data Table on US - Market size and forecast 2022-2027 ($ billion)
Exhibits89: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on China - Market size and forecast 2022-2027 ($ billion)
Exhibits92: Data Table on China - Market size and forecast 2022-2027 ($ billion)
Exhibits93: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on India - Market size and forecast 2022-2027 ($ billion)
Exhibits96: Data Table on India - Market size and forecast 2022-2027 ($ billion)
Exhibits97: Chart on India - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on India - Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on Russia - Market size and forecast 2022-2027 ($ billion)
Exhibits100: Data Table on Russia - Market size and forecast 2022-2027 ($ billion)
Exhibits101: Chart on Russia - Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on Russia - Year-over-year growth 2022-2027 (%)
Exhibits103: Chart on Mexico - Market size and forecast 2022-2027 ($ billion)
Exhibits104: Data Table on Mexico - Market size and forecast 2022-2027 ($ billion)
Exhibits105: Chart on Mexico - Year-over-year growth 2022-2027 (%)
Exhibits106: Data Table on Mexico - Year-over-year growth 2022-2027 (%)
Exhibits107: Market opportunity By Geographical Landscape ($ billion)
Exhibits108: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits109: Impact of drivers and challenges in 2022 and 2027
Exhibits110: Overview on Criticality of inputs and Factors of differentiation
Exhibits111: Overview on factors of disruption
Exhibits112: Impact of key risks on business
Exhibits113: Vendors covered
Exhibits114: Matrix on vendor position and classification
Exhibits115: Abbott Laboratories - Overview
Exhibits116: Abbott Laboratories - Business segments
Exhibits117: Abbott Laboratories - Key offerings
Exhibits118: Abbott Laboratories - Segment focus
Exhibits119: Astellas Pharma Inc. - Overview
Exhibits120: Astellas Pharma Inc. - Product / Service
Exhibits121: Astellas Pharma Inc. - Key news
Exhibits122: Astellas Pharma Inc. - Key offerings
Exhibits123: AstraZeneca Plc - Overview
Exhibits124: AstraZeneca Plc - Product / Service
Exhibits125: AstraZeneca Plc - Key news
Exhibits126: AstraZeneca Plc - Key offerings
Exhibits127: Aurobindo Pharma Ltd. - Overview
Exhibits128: Aurobindo Pharma Ltd. - Product / Service
Exhibits129: Aurobindo Pharma Ltd. - Key offerings
Exhibits130: Bayer AG - Overview
Exhibits131: Bayer AG - Business segments
Exhibits132: Bayer AG - Key news
Exhibits133: Bayer AG - Key offerings
Exhibits134: Bayer AG - Segment focus
Exhibits135: Boehringer Ingelheim International GmbH - Overview
Exhibits136: Boehringer Ingelheim International GmbH - Business segments
Exhibits137: Boehringer Ingelheim International GmbH - Key news
Exhibits138: Boehringer Ingelheim International GmbH - Key offerings
Exhibits139: Boehringer Ingelheim International GmbH - Segment focus
Exhibits140: Bristol Myers Squibb Co. - Overview
Exhibits141: Bristol Myers Squibb Co. - Product / Service
Exhibits142: Bristol Myers Squibb Co. - Key news
Exhibits143: Bristol Myers Squibb Co. - Key offerings
Exhibits144: Daiichi Sankyo Co. Ltd. - Overview
Exhibits145: Daiichi Sankyo Co. Ltd. - Business segments
Exhibits146: Daiichi Sankyo Co. Ltd. - Key news
Exhibits147: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibits148: Daiichi Sankyo Co. Ltd. - Segment focus
Exhibits149: Dr Reddys Laboratories Ltd. - Overview
Exhibits150: Dr Reddys Laboratories Ltd. - Business segments
Exhibits151: Dr Reddys Laboratories Ltd. - Key offerings
Exhibits152: Dr Reddys Laboratories Ltd. - Segment focus
Exhibits153: Eli Lilly and Co. - Overview
Exhibits154: Eli Lilly and Co. - Product / Service
Exhibits155: Eli Lilly and Co. - Key offerings
Exhibits156: GlaxoSmithKline Plc - Overview
Exhibits157: GlaxoSmithKline Plc - Business segments
Exhibits158: GlaxoSmithKline Plc - Key news
Exhibits159: GlaxoSmithKline Plc - Key offerings
Exhibits160: GlaxoSmithKline Plc - Segment focus
Exhibits161: Johnson and Johnson Services Inc. - Overview
Exhibits162: Johnson and Johnson Services Inc. - Business segments
Exhibits163: Johnson and Johnson Services Inc. - Key news
Exhibits164: Johnson and Johnson Services Inc. - Key offerings
Exhibits165: Johnson and Johnson Services Inc. - Segment focus
Exhibits166: Merck and Co. Inc. - Overview
Exhibits167: Merck and Co. Inc. - Business segments
Exhibits168: Merck and Co. Inc. - Key news
Exhibits169: Merck and Co. Inc. - Key offerings
Exhibits170: Merck and Co. Inc. - Segment focus
Exhibits171: Pfizer Inc. - Overview
Exhibits172: Pfizer Inc. - Product / Service
Exhibits173: Pfizer Inc. - Key news
Exhibits174: Pfizer Inc. - Key offerings
Exhibits175: Viatris Inc. - Overview
Exhibits176: Viatris Inc. - Business segments
Exhibits177: Viatris Inc. - Key offerings
Exhibits178: Viatris Inc. - Segment focus
Exhibits179: Inclusions checklist
Exhibits180: Exclusions checklist
Exhibits181: Currency conversion rates for US$
Exhibits182: Research methodology
Exhibits183: Validation techniques employed for market sizing
Exhibits184: Information sources
Exhibits185: List of abbreviations